Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-09-17

FDA Approved: LAMIVUDINE AND ZIDOVUDINE — Original Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Camber Pharmaceuticals' lamivudine and zidovudine as an original application, a generic fixed-dose combination for HIV-1 infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lamivudine and Zidovudine (Lamivudine and Zidovudine)

Snippet

ORIG AP for LAMIVUDINE AND ZIDOVUDINE (LAMIVUDINE AND ZIDOVUDINE)